XBI

SPDR S&P Biotech ETF

Down$79.78
$-1.08
(-1.34%)
As of 7:30:00 PM EDT | 1/23/19  |  Market Closed

XBI Trading Data

Open

$81.34

Low Price

$78.6

High Price

$81.77

Previous Last Price

$80.86

Bid Size

$79.71 X 1600

Ask Size

$79.85 X 1700

XBI Portfolio Data

AUM

$3,954,670,400

Shares

48,950

PE Ratio

17.32

Price / Book Ratio

4.4

Expense Ratio

0.35

Net Asset Value

$80.79

Volume

Volume

6,002,091

Avg. Volume (YDT)

5,793,380

Dollar Volume

$437,392,820

Weekly Avg. Volume

4,961,080

Monthly Avg. Volume

6,262,025

Quarterly Avg. Volume

6,958,751

XBI Fund Description

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

XBI Chart

XBI Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Biotech ETF

Inception Date

2006-01-31

Asset Class

Equity

Asset Class Size

Biotech

XBI Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XBI Holdings

Top 10 Holdings

Loxo Oncology Inc (LOXO)
2.07%
Mirati Therapeutics Inc. (MRTX)
1.77%
SAGE Therapeutics Inc. (SAGE)
1.68%
Portola Pharmaceuticals Inc. (PTLA)
1.66%
Neurocrine Biosciences Inc. (NBIX)
1.58%
Celgene Corporation (CELG)
1.56%
bluebird bio Inc. (BLUE)
1.55%
Seattle Genetics Inc. (SGEN)
1.5%
FibroGen Inc. (FGEN)
1.48%
ACADIA Pharmaceuticals Inc. (ACAD)
1.46%

Total XBI Holdings

Total Holdings: 123

Loxo Oncology Inc (LOXO)
2.07%
Mirati Therapeutics Inc. (MRTX)
1.77%
SAGE Therapeutics Inc. (SAGE)
1.68%
Portola Pharmaceuticals Inc. (PTLA)
1.66%
Neurocrine Biosciences Inc. (NBIX)
1.58%
Celgene Corporation (CELG)
1.56%
bluebird bio Inc. (BLUE)
1.55%
Seattle Genetics Inc. (SGEN)
1.5%
FibroGen Inc. (FGEN)
1.48%
ACADIA Pharmaceuticals Inc. (ACAD)
1.46%
Incyte Corporation (INCY)
1.46%
Amicus Therapeutics Inc. (FOLD)
1.43%
Ultragenyx Pharmaceutical Inc. (RARE)
1.43%
Global Blood Therapeutics Inc (GBT)
1.42%
Clovis Oncology Inc. (CLVS)
1.42%
Exact Sciences Corporation (EXAS)
1.42%
Vertex Pharmaceuticals Incorporated (VRTX)
1.41%
Puma Biotechnology Inc. (PBYI)
1.37%
Regeneron Pharmaceuticals Inc. (REGN)
1.35%
Array BioPharma Inc. (ARRY)
1.35%
Ionis Pharmaceuticals Inc. (IONS)
1.35%
Madrigal Pharmaceuticals Inc. (MDGL)
1.34%
Heron Therapeutics Inc (HRTX)
1.33%
Agios Pharmaceuticals Inc. (AGIO)
1.33%
Exelixis Inc. (EXEL)
1.32%
United Therapeutics Corporation (UTHR)
1.32%
Biogen Inc. (BIIB)
1.32%
Alnylam Pharmaceuticals Inc (ALNY)
1.32%
Alexion Pharmaceuticals Inc. (ALXN)
1.32%
Amgen Inc. (AMGN)
1.31%
Gilead Sciences Inc. (GILD)
1.3%
Intercept Pharmaceuticals Inc. (ICPT)
1.29%
Spark Therapeutics Inc. (ONCE)
1.29%
BioMarin Pharmaceutical Inc. (BMRN)
1.29%
AbbVie Inc. (ABBV)
1.29%
AnaptysBio Inc. (ANAB)
1.28%
Alkermes Plc (ALKS)
1.28%
REGENXBIO Inc. (RGNX)
1.27%
Sarepta Therapeutics Inc. (SRPT)
1.26%
PTC Therapeutics Inc. (PTCT)
1.26%
TESARO Inc. (TSRO)
1.25%
Viking Therapeutics Inc. (VKTX)
1.19%
Myriad Genetics Inc. (MYGN)
1.17%
Blueprint Medicines Corp. (BPMC)
1.17%
Arrowhead Pharmaceuticals Inc. (ARWR)
1.13%
Esperion Therapeutics Inc. (ESPR)
1.1%
Sangamo Therapeutics Inc. (SGMO)
1.1%
Repligen Corporation (RGEN)
1.08%
Arena Pharmaceuticals Inc. (ARNA)
1.07%
Ligand Pharmaceuticals Incorporated (LGND)
1.06%
Insmed Incorporated (INSM)
1.05%
Emergent BioSolutions Inc. (EBS)
1.04%
Genomic Health Inc. (GHDX)
1.01%
Enanta Pharmaceuticals Inc. (ENTA)
0.95%
Immunomedics Inc. (IMMU)
0.87%
OPKO Health Inc. (OPK)
0.84%
Spectrum Pharmaceuticals Inc. (SPPI)
0.84%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.82%
Atara Biotherapeutics Inc (ATRA)
0.8%
Editas Medicine Inc. (EDIT)
0.8%
Invitae Corp. (NVTA)
0.79%
Vanda Pharmaceuticals Inc. (VNDA)
0.75%
CareDx Inc. (CDNA)
0.71%
Acceleron Pharma Inc (XLRN)
0.7%
Intrexon Corporation (XON)
0.7%
Halozyme Therapeutics Inc. (HALO)
0.66%
ImmunoGen Inc. (IMGN)
0.65%
Radius Health Inc (RDUS)
0.62%
Aimmune Therapeutics Inc (AIMT)
0.62%
Verastem Inc. (VSTM)
0.61%
Acorda Therapeutics Inc. (ACOR)
0.6%
AMAG Pharmaceuticals Inc. (AMAG)
0.59%
Intellia Therapeutics Inc. (NTLA)
0.58%
Eagle Pharmaceuticals Inc. (EGRX)
0.58%
Iovance Biotherapeutics Inc (IOVA)
0.57%
Audentes Therapeutics Inc. (BOLD)
0.57%
Cara Therapeutics Inc (CARA)
0.55%
Natera Inc. (NTRA)
0.55%
Alder Biopharmaceuticals Inc. (ALDR)
0.54%
Flexion Therapeutics Inc. (FLXN)
0.53%
Vericel Corporation (VCEL)
0.53%
Dynavax Technologies Corporation (DVAX)
0.51%
Coherus BioSciences Inc. (CHRS)
0.48%
Momenta Pharmaceuticals Inc. (MNTA)
0.44%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
0.44%
Xencor Inc. (XNCR)
0.4%
G1 Therapeutics Inc. (GTHX)
0.38%
Fate Therapeutics Inc. (FATE)
0.37%
Karyopharm Therapeutics Inc. (KPTI)
0.36%
Epizyme Inc. (EPZM)
0.35%
Novavax Inc. (NVAX)
0.35%
Progenics Pharmaceuticals Inc. (PGNX)
0.35%
TG Therapeutics Inc. (TGTX)
0.34%
Retrophin Inc. (RTRX)
0.34%
Solid Biosciences Inc. (SLDB)
0.31%
Denali Therapeutics Inc. (DNLI)
0.3%
Dicerna Pharmaceuticals Inc. (DRNA)
0.29%
CytomX Therapeutics Inc. (CTMX)
0.28%
Deciphera Pharmaceuticals Inc. (DCPH)
0.28%
ArQule Inc. (ARQL)
0.24%
Sorrento Therapeutics Inc. (SRNE)
0.23%
Rigel Pharmaceuticals Inc. (RIGL)
0.23%
Prothena Corp. Plc (PRTA)
0.22%
Inovio Pharmaceuticals Inc. (INO)
0.22%
Allakos Inc. (ALLK)
0.2%
BioCryst Pharmaceuticals Inc. (BCRX)
0.19%
MacroGenics Inc. (MGNX)
0.18%
PDL BioPharma Inc. (PDLI)
0.17%
Five Prime Therapeutics Inc. (FPRX)
0.17%
GlycoMimetics Inc. (GLYC)
0.17%
Rhythm Pharmaceuticals Inc. (RYTM)
0.16%
Athenex Inc. (ATNX)
0.16%
Akebia Therapeutics Inc. (AKBA)
0.15%
Kura Oncology Inc. (KURA)
0.15%
Apellis Pharmaceuticals Inc. (APLS)
0.14%
ZIOPHARM Oncology Inc. (ZIOP)
0.14%
Stemline Therapeutics Inc. (STML)
0.13%
Achillion Pharmaceuticals Inc. (ACHN)
0.13%
Lexicon Pharmaceuticals Inc. (LXRX)
0.12%
STATE STREET INSTL US GOVERNME STIF USD (Unassigned)
0.12%
Cytokinetics Incorporated (CYTK)
0.09%
SPDR S & P Biotech ETF (XBI)
0%
U.S. Dollar
0%

XBI Technicals

Alpha

-8

Beta

1.65

Leverage

Long

Standard Deviation

8.58

XBI Dividends

Dividend Date

2018-12-21

Latest Dividend

0.012

Annual Dividend

0.2

Annual Dividend Rate

0.2

Annual Dividend Yield

0.25

XBI Performance

YTD Return

11.19%

1 Year Return

-16.74%

3 Year Return

59.96%

5 Year Return

61.49%

10 Year Return

359.69%

XBI Related Articles